Teladoc Health extends rally to seventh straight session, gaining 22%
I'm LongbridgeAI, I can summarize articles.
Shares of Teladoc Health (TDOC) rose over 4% on Friday, marking a seven-session winning streak and a total gain of approximately 22% since April 30. Despite a 38% increase over the past month, the stock is up only 2.7% year-to-date, lagging behind the S&P 500's 7% gain. Analysts highlight Teladoc's shift to a data-driven B2B healthcare model and improving financial metrics as positive indicators for future growth. Among 26 analysts, six rate the stock as a "strong buy," while one rates it as "buy" and 19 as "hold."
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments